Formation of new blood vessels in the heart can be studied in cell cultures

ALTEX. 2007:24 Spec No:35-8.

Abstract

Controlled induction of the formation of new microvessels, i.e., therapeutic angiogenesis, may be used one day to treat patients that for example had suffered a myocardial infarction. Experimental models of angiogenesis in the heart in vivo substantially stress the animal. We therefore developed a model of angiogenesis of the heart in vitro, where mouse and rat heart pieces are stimulated under controlled conditions in a three dimensional matrix. Capillary-like sprouts emerging in these cultures represent early to midterm steps of angiogenesis and can be quantified to study potential angiogenic compounds and underlying mechanisms.

MeSH terms

  • Angiogenesis Inducing Agents / pharmacology*
  • Angiotensin II / pharmacology
  • Animals
  • Becaplermin
  • Capillaries / cytology
  • Capillaries / drug effects
  • Capillaries / physiology*
  • Cell Culture Techniques / methods*
  • Coronary Circulation / drug effects
  • Coronary Circulation / physiology*
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects
  • Fibrin / physiology
  • Fibroblast Growth Factor 2 / pharmacology
  • Gels
  • Heart / physiology*
  • Humans
  • Mice
  • Muscle Tonus / drug effects
  • Muscle Tonus / physiology
  • Myocardium / cytology
  • Myocardium / enzymology
  • Neovascularization, Physiologic* / drug effects
  • Nitric Oxide / pharmacology
  • Nitric Oxide Synthase Type II / deficiency
  • Platelet-Derived Growth Factor / pharmacology
  • Proto-Oncogene Proteins c-sis
  • Rats
  • Vasodilation / drug effects

Substances

  • Angiogenesis Inducing Agents
  • Gels
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • Fibroblast Growth Factor 2
  • Angiotensin II
  • Becaplermin
  • Nitric Oxide
  • Fibrin
  • Nitric Oxide Synthase Type II